A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Stanford University
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
University of Washington
Fred Hutchinson Cancer Center
University Health Network, Toronto
Massachusetts General Hospital
M.D. Anderson Cancer Center
St. Petersburg State Pavlov Medical University
University of Chicago
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
RWTH Aachen University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Icahn School of Medicine at Mount Sinai
University of Birmingham
Institute of Hematology & Blood Diseases Hospital, China
Vanderbilt-Ingram Cancer Center
St. Petersburg State Pavlov Medical University
OHSU Knight Cancer Institute
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Multinational Center for Quality of Life Research, Russia
Zhengzhou University
University of Michigan Rogel Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
University Health Network, Toronto
Seoul National University Hospital
M.D. Anderson Cancer Center
Icahn School of Medicine at Mount Sinai